American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline for Management of Hereditary Breast Cancer
Author:
Affiliation:
1. Ramsay Sime Darby Healthcare, Malaysia
2. University Malaya, Kuala Lumpur, Malaysia
3. Breast Surgery Section, International Center for the Study of Breast Cancer Subtypes, Weill Cornell Medicine, New York, New York
Publisher
American Medical Association (AMA)
Subject
Surgery
Link
https://jamanetwork.com/journals/jamasurgery/articlepdf/2775055/jamasurgery_yip_2021_gs_200008_1614638683.4258.pdf
Reference7 articles.
1. Gene-panel sequencing and the prediction of breast-cancer risk.;Easton;N Engl J Med,2015
2. Management of hereditary breast cancer: ASCO, ASTRO, and SSO guideline.;McGuire;Ann Surg Oncol,2020
3. Prognostic impact of breast-conserving therapy versus mastectomy of BRCA1/2 mutation carriers compared with noncarriers in a consecutive series of young breast cancer patients.;van den Broek;Ann Surg,2019
4. Oncologic safety of prophylactic nipple-sparing mastectomy in a population with BRCA mutations.;Jakub;JAMA Surg,2018
5. Clinical implications of germline mutations in breast cancer.;Schon;Breast Cancer Res Treat,2018
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prevention, diagnosis and clinical management of hereditary breast cancer beyond BRCA1/2 genes;Cancer Treatment Reviews;2024-09
2. AcornHRD: an HRD algorithm highly associated with anthracycline-based neoadjuvant chemotherapy in breast cancer in China;European Journal of Medical Research;2024-07-16
3. Consenso mexicano de cáncer mamario. Manejo del cáncer de mama temprano;Gaceta Mexicana de Oncolog�a;2024-06-25
4. A nomogram model combining ultrasound-based radiomics features and clinicopathological factors to identify germline BRCA1/2 mutation in invasive breast cancer patients;Heliyon;2024-01
5. AcornHRD: an HRD algorithm highly associated with anthracycline-based neoadjuvant chemotherapy in breast cancer in China;2023-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3